<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39458415</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Coinfection of <i>Toxoplasma gondii</i> and Other Microorganisms: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2106</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms12102106</ELocationID><Abstract><AbstractText>Toxoplasmosis is a disease caused by the intracellular protozoan <i>Toxoplasma gondii</i>, which has infected a third of the global population. Immunocompromised individuals and children with congenital disorders are most likely to be impacted by toxoplasmosis, and accurate diagnosis is essential. Toxoplasmosis is associated with HIV, schizophrenia, and diabetes. However, few studies have analyzed the association with other microorganisms. The purpose of this study was to determine the prevalence of coinfection of <i>Toxoplasma gondii</i> with other pathogens. From November 1997 to June 2024, PubMed, Science Direct, LAT index, Web of Science, Google Scholar, and Research Gate were searched. The keywords used were "<i>Toxoplasma</i> and microorganism coinfection", "<i>Toxoplasma</i> coinfection and parasites", "<i>Toxoplasma</i> coinfection and Protozoans or Bacteria or Helminths or Nematodes or Trematodes or Mycobacterium", "<i>Toxoplasma gondii</i> in coinfection with virus", and "Human Toxoplasmosis and coinfection". Next, OpenMeta Analyst Software version 12.11 was used for meta-analysis, creating forest plots, and determining heterogeneity I<sup>2</sup>. A total of 17,535 patients in 48 articles, of whom 5848 were seropositive to <i>T. gondii</i>, were included in this review. Population studies showed that the prevalence of virus infection was most frequent (32%), followed by parasites (18.4%), bacteria (29.7%), and fungi (5.8%). The pooled prevalence of coinfection was found to be 29.1%, with a lower bound of 0.232, an upper bound of 0.350, a standard error of 0.030, and <i>p</i> &lt; 0.001. Heterogeneity (I<sup>2</sup>) was 99.12%, <i>p</i> &lt; 0.001, with a global variance tau2 = 0.042. <i>Toxoplasma gondii</i> is an opportunist that mainly affects immunocompromised populations. The main coinfections were found to be viral infections, with HIV ranking first, followed by cytomegalovirus, hepatitis B and C, rubella, herpes simplex 1 and 2, SARS-CoV-2, and coxsackie virus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galván-Ramírez</LastName><ForeName>María de la Luz</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0002-5581-4322</Identifier><AffiliationInfo><Affiliation>Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soto-Hernández</LastName><ForeName>Eber Eduardo</ForeName><Initials>EE</Initials><Identifier Source="ORCID">0009-0000-9284-9519</Identifier><AffiliationInfo><Affiliation>Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bojórquez-Pérez</LastName><ForeName>Rocío</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5776-7005</Identifier><AffiliationInfo><Affiliation>Escuela de Biología, Universidad Autónoma de Sinaloa, Culiacán 80050, Sinaloa, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bacteria</Keyword><Keyword MajorTopicYN="N">coinfection</Keyword><Keyword MajorTopicYN="N">parasites</Keyword><Keyword MajorTopicYN="N">toxoplasmosis</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39458415</ArticleId><ArticleId IdType="pmc">PMC11510090</ArticleId><ArticleId IdType="doi">10.3390/microorganisms12102106</ArticleId><ArticleId IdType="pii">microorganisms12102106</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Galván-Ramírez M.L., Mondragón Flores R.  Toxoplasmosis Humana. 1st ed. Ecorfan; Ciudad de México, México: 2017.  [(accessed on 5 August 2024)].  Available online:  https://www.ecorfan.org/libros/BOOK_TOXOPLASMOSIS.pdf.</Citation></Reference><Reference><Citation>Lang C., Gross U., Lüder C.G. Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol. Res. 2007;100:191–203. doi: 10.1007/s00436-006-0306-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00436-006-0306-9</ArticleId><ArticleId IdType="pubmed">17024357</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey J.P. The history of Toxoplasma gondii—The first 100 years. J. Eukaryot. Microbiol. 2008;55:467–475. doi: 10.1111/j.1550-7408.2008.00345.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1550-7408.2008.00345.x</ArticleId><ArticleId IdType="pubmed">19120791</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z.D., Wang S.C., Liu H.H., Ma H.Y., Li Z.Y., Wei F. Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: A systematic review and meta-analysis. Lancet HIV. 2017;4:177–188. doi: 10.1016/S2352-3018(17)30005-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3018(17)30005-X</ArticleId><ArticleId IdType="pubmed">28159548</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M., Mishra A., Buchanan R.L., Dubey J.P., Hill D.E., Gamble H.R., Pradhan A.K. Quantifying the Risk of Human Toxoplasma gondii Infection Due to Consumption of Domestically Produced Lamb in the United States. J. Food Prot. 2016;79:1181–1187. doi: 10.4315/0362-028X.JFP-15-591.</Citation><ArticleIdList><ArticleId IdType="doi">10.4315/0362-028X.JFP-15-591</ArticleId><ArticleId IdType="pubmed">27357038</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedges D.W., Gale S.D., Erickson L.D. Infectious Diseases in Neurocognitive and Neuropsychiatric Medicine. Oxford University Press; Oxford, UK: 2024.</Citation></Reference><Reference><Citation>Moher A.L., Tetzlaff Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed Khan K., Bueno-Cavanillas A., Zamora J. Revisiones sistemáticas en cinco pasos: IV. Cómo sintetizar los resultados [Systematic reviews in five steps: IV. Summarizing the evidence] Semergen. 2022;48:101785. doi: 10.1016/j.semerg.2022.02.006. (In Spanish)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semerg.2022.02.006</ArticleId><ArticleId IdType="pubmed">35599147</ArticleId></ArticleIdList></Reference><Reference><Citation>Galván-Ramírez M.L., Valdez Alvarado V., Vargas Gutierrez G., Jiménez González O., García Cosio C., Vielma Sandoval M. Prevalence of IgG and IgM anti-Toxoplasma antibodies in patients with HIV and acquired immunodeficiency syndrome (AIDS) Rev. Soc. Bras. Med. Trop. 1997;30:465–467. doi: 10.1590/S0037-86821997000600004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0037-86821997000600004</ArticleId><ArticleId IdType="pubmed">9428183</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpore J., Savadogo A., Ilboudo D., Nadambega M.C., Esposito M., Yara J., Pignatelli S., Pietra V., Musumeci S. Toxoplasma gondii, HCV, and HBV Seroprevalence and Co-Infection Among HIV-Positive and Negative Pregnant Women in Burkina Faso. J. Med. Virol. 2006;78:730–733. doi: 10.1002/jmv.20615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20615</ArticleId><ArticleId IdType="pubmed">16628587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lago E.G., Conrado G.S., Piccoli C.S., Carvalho R.L., Bender A.L. Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 2009;28:345–351. doi: 10.1007/s10096-008-0631-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-008-0631-2</ArticleId><ArticleId IdType="pubmed">18855029</ArticleId></ArticleIdList></Reference><Reference><Citation>Pérez C.C., Cerón A.I., Fuentes L.G., Zañartu S.C., Balcells M.M.E., Ajenjo H.C., Rabagliati B.R., Labarca L.J., Acuña L.G. Coinfecciones por virus hepatitis B, virus hepatitis C, Treponema pallidum y Toxoplasma gondii en la cohorte de pacientes VIH positivos en control en la Pontificia Universidad Católica de Chile. Rev. Med. Chil. 2009;137:641–648. doi: 10.4067/S0034-98872009000500007.</Citation><ArticleIdList><ArticleId IdType="doi">10.4067/S0034-98872009000500007</ArticleId><ArticleId IdType="pubmed">19701553</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Madi M.A., Behnke J.M., Dabritzm H.A. Toxoplasma gondii seropositivity and co-infection with TORCH pathogens in high-risk patients from Qatar. Am. J. Trop. Med. Hyg. 2010;82:626–633. doi: 10.4269/ajtmh.2010.09-0530.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2010.09-0530</ArticleId><ArticleId IdType="pmc">PMC2844547</ArticleId><ArticleId IdType="pubmed">20348511</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.R., Gong R.Y., Li Y.P., Bai Y., You F., Deng S. Research on HIV/Toxoplasma gondii coinfection and cytokine levels among intravenous drug users. Parasite Immunol. 2010;32:161–164. doi: 10.1111/j.1365-3024.2009.01174.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3024.2009.01174.x</ArticleId><ArticleId IdType="pubmed">20070830</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalakshmi B., Therese K.L., Devipriya U., Pushpalatha V., Margarita S., Madhavan H.N. Infectious etiology of congenital cataract based on TORCHES screening in a tertiary eye hospital in Chennai, Tamil Nadu, India. Indian J. Med. Res. 2010;131:559–564.</Citation><ArticleIdList><ArticleId IdType="pubmed">20424308</ArticleId></ArticleIdList></Reference><Reference><Citation>Blay E.A., Ghansah A., Otchere J., Koku R., Kwofie K.D., Bimi L., Takashi S., Ohta N., Ayi I. Congenital toxoplasmosis and pregnancy malaria detection post-partum: Effective diagnosis and its implication for efficient management of congenital infection. Parasitol. Int. 2015;64:603–608. doi: 10.1016/j.parint.2015.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parint.2015.08.004</ArticleId><ArticleId IdType="pubmed">26264261</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchioro A., Colli C., Ferreira É.C., Viol B., Araújo S., Falavigna-Guilherme A. Risk factors associated with toxoplasmosis and toxocariasis in populations of children from nine cities in southern Brazil. J. Helminthol. 2015;89:8–32. doi: 10.1017/S0022149X14000212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022149X14000212</ArticleId><ArticleId IdType="pubmed">24725417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Lan C., Zhang L., Zhang H., Yao Z., Wang D., Ma J., Deng J., Liu S. Seroprevalence of Toxoplasma gondii infection among patients with hand, foot and mouth disease in Henan, China: A hospital-based study. Infect. Dis. Poverty. 2015;4:1–5. doi: 10.1186/s40249-015-0088-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-015-0088-3</ArticleId><ArticleId IdType="pmc">PMC4675030</ArticleId><ArticleId IdType="pubmed">26653890</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Ye M., Zhou Y.-H., Liu F.-L., Duo L., Li H., Pang W., Zheng Y.-T. High seroprevalence of Toxoplasma gondii and HIV-1 coinfection among drug users in Yunnan province, southwest China. Sci. China Life Sci. 2016;59:857–859. doi: 10.1007/s11427-015-0358-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-015-0358-y</ArticleId><ArticleId IdType="pubmed">27294834</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo-Tapia A.N., Díaz-Peña R. Seroprevalencia contra Toxoplasma gondii en pacientes pediátricos que viven con VIH. Rev. Mex Pediatr. 2016;83:191–197.</Citation></Reference><Reference><Citation>El-Sayed N.M., Ramadan M.E., Ramadan M.E. Toxoplasma gondii Infection and Chronic Liver Diseases: Evidence of an association. Trop. Med. Infect. Dis. 2016;1:7. doi: 10.3390/tropicalmed1010007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed1010007</ArticleId><ArticleId IdType="pmc">PMC6082049</ArticleId><ArticleId IdType="pubmed">30270858</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti S., Ghasemi F.S., Abdoli A., Piroozmand A., Mousavi S.G., Fakhrie-Kashan Z. ToRCH “coinfections” are associated with increased risk of abortion in pregnant women. Congenit. Anom. 2016;56:73–78. doi: 10.1111/cga.12138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cga.12138</ArticleId><ArticleId IdType="pubmed">26499091</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashaly M., Nabih N., Fawzy I.M., El Henawy A.A. Tuberculosis/toxoplasmosis coinfection in Egyptian patients: A reciprocal impact. Asian Pac. J. Trop. Med. 2017;10:315–319. doi: 10.1016/j.apjtm.2017.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apjtm.2017.03.012</ArticleId><ArticleId IdType="pubmed">28442117</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos P., Telmo P., Lehmann L., Mattos G., Klafke G., Lorenzi C., Hirsch C., Lemos L., Berne M., Gonçalves C., et al. Risk and other factors associated with toxoplasmosis and toxocariasis in pregnant women from southern Brazil. J. Helminthol. 2017;91:534–538. doi: 10.1017/S0022149X16000481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022149X16000481</ArticleId><ArticleId IdType="pubmed">27411883</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.J., Zhao Y.H., Zhang X.Y., Sun X.J., Liu Y.Q., Hou Y.J., Wu J.Q., Jia H., Ha Y.N., Dong W., et al. First Report of Toxoplasma gondii Infection in Tuberculosis Patients in China. Vector-Borne Zoonotic Dis. 2017;17:799–803. doi: 10.1089/vbz.2017.2151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vbz.2017.2151</ArticleId><ArticleId IdType="pubmed">29040020</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazari N., Bozorgomid A., Janbakhsh A., Bashiri F. Toxoplasma gondii and human immunodeficiency virus coinfection in western Iran: A cross sectional study. Asian Pac. J. Trop. Med. 2018;11:58–62. doi: 10.4103/1995-7645.223562.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1995-7645.223562</ArticleId></ArticleIdList></Reference><Reference><Citation>De-La-Torre A., Valdés-Camacho J., de Mesa C.L., Uauy-Nazal A., Zuluaga J.D., Ramírez-Páez L.M., Durán F., Torres-Morales E., Triviño J., Murillo M., et al. Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin. BMC Infect. Dis. 2019;19:91. doi: 10.1186/s12879-018-3613-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3613-8</ArticleId><ArticleId IdType="pmc">PMC6347798</ArticleId><ArticleId IdType="pubmed">30683065</ArticleId></ArticleIdList></Reference><Reference><Citation>Raissi V., Taghipour A., Navi Z., Etemadi S., Sohrabi Z., Sohrabi N., Getso M., Shamsaei S., Karami M.F., Raiesi O. Seroprevalence of Toxoplasma gondii and Toxocara spp. infections among pregnant women with and without previous abortions in the west of Iran. J. Obstet. Gynaecol. Res. 2020;46:382–388. doi: 10.1111/jog.14184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jog.14184</ArticleId><ArticleId IdType="pubmed">31953906</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakari M.M., Isah A.Y., Offiong R., Yunusa T., Abdullahi I.N. Serological survey and risk factors associated with Toxoplasma gondii infection among HIV-infected pregnant women attending Abuja tertiary hospital, Nigeria. Malawi Med. J. 2020;32:169–176. doi: 10.4314/mmj.v32i3.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/mmj.v32i3.9</ArticleId><ArticleId IdType="pmc">PMC7812142</ArticleId><ArticleId IdType="pubmed">33488988</ArticleId></ArticleIdList></Reference><Reference><Citation>Najm M.A., Abdel Razaak H.A., Fahad H. Detect the infection with rubella virus and toxoplasmosis in pregnancy causes suffering from early abortion by using real time PCR. Médico-Legal Update. 2020;20:397–402.</Citation></Reference><Reference><Citation>Sharaf-El-Deen A., Shalan S.H., Agha F.A., Brakat M.M. Toxoplasma gondii as a possible risk factor for COVID-19 severity: A case-control study. Egypt. J. Med. Microbiol. 2021;30:125–132. doi: 10.51429/EJMM30217.</Citation><ArticleIdList><ArticleId IdType="doi">10.51429/EJMM30217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral M.T., Evers F., de Souza Lima N.B., Pinto-Ferreira F., Breganó J.W., Ragassi U.M., Rubinsky-Elefant G., Freire R.L., Navarro I.T., Mitsuka-Breganó r. Socioeconomic factors associated with infection by Toxoplasma gondii and Toxocara canis in children. Transbound Emerg. Dis. 2021;69:1589–1595. doi: 10.1111/tbed.14129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbed.14129</ArticleId><ArticleId IdType="pubmed">33908184</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaela E., Nkodila A., Bepouka B., Longokolo M., Mandina M., Mayasi N., Magbetha B., Kiazayayako F., Mbonza A., Mabunu T., et al. Cerebral Toxoplasmosis and Associated Risk Factors in People Living with HIV in Kinshasa, Democratic Republic of Congo. Open Access Libr. J. 2021;8:e8048. doi: 10.4236/oalib.1108048.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/oalib.1108048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaffari S., Kalantari N., Gorgani-Firouzjaee T., Bayani M., Jalali F., Daroonkola M.A. Is COVID-19 associated with latent toxoplasmosis? Environ. Sci. Pollut. Res. 2021;28:67886–67890. doi: 10.1007/s11356-021-17126-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-021-17126-w</ArticleId><ArticleId IdType="pmc">PMC8542425</ArticleId><ArticleId IdType="pubmed">34693492</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Wang F., Wang C., Tang X., Liu X., Li S., Waterfield N.R., Wang W., Suo X., Yang G. Detection of Pneumocystis jirovecii and Toxoplasma gondii in patients with lung infections by a duplex qPCR assay. PLoS. Negl. Trop. Dis. 2021;15:e0010025. doi: 10.1371/journal.pntd.0010025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0010025</ArticleId><ArticleId IdType="pmc">PMC8682901</ArticleId><ArticleId IdType="pubmed">34919557</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsaei M., Spotin A., Matini M., Mahjub H., Aghazadeh M., Ghahremani G., Taherkhani H. Prevalence of toxoplasmosis in patients infected with tuberculosis; a sero-molecular case-control study in northwest Iran. Comp. Immunol. Microbiol. Infect. Dis. 2022;81:101720. doi: 10.1016/j.cimid.2021.101720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cimid.2021.101720</ArticleId><ArticleId IdType="pubmed">34990934</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazeri M., Nakhaei M., Fakhar M., Pazoki H., Pagheh A.S., Nazar E. Exploring the Association between Latent Toxoplasma gondii Infection and COVID-19 in Hospitalized Patients: First Registry—Based Study. Acta Parasitol. 2022;67:1172–1179. doi: 10.1007/s11686-022-00559-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11686-022-00559-9</ArticleId><ArticleId IdType="pmc">PMC9094600</ArticleId><ArticleId IdType="pubmed">35545737</ArticleId></ArticleIdList></Reference><Reference><Citation>Hany M., Ibrahim A., Hassan M., Hend S.M. Incidence of Toxoplasma gondii, Entamoeba histolytica and Schistosoma mansoni Infections Among Hepatitis C Virus Patients in Egypt. J. Adv. Med. Biomed. Res. 2022;30:431–437. doi: 10.30699/jambs.30.142.431.</Citation><ArticleIdList><ArticleId IdType="doi">10.30699/jambs.30.142.431</ArticleId></ArticleIdList></Reference><Reference><Citation>Raissi V., Sohrabi Z., Alizadeh G., Etemadi S., Raiesi O., Bagherpoor M.R., Samani Z.B., Fatemeh P., Hashemibaghi Z., Yousefnia HIbrahim A. Evaluation of antinuclear antibodies in pregnant women with abortion with toxocariasis and toxoplasmosis in Iran. Turk. Bull. Hyg. Exp. Biol. 2022;79:217–228. doi: 10.5505/TurkHijyen.2022.69009.</Citation><ArticleIdList><ArticleId IdType="doi">10.5505/TurkHijyen.2022.69009</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali M.S., Saheb E.J. Serum levels of C-reactive protein and ferritin in COVID-19 patients infected with Toxoplasma gondii. Ann. Parasitol. 2022;68:47–54. doi: 10.17420/ap6801.407.</Citation><ArticleIdList><ArticleId IdType="doi">10.17420/ap6801.407</ArticleId><ArticleId IdType="pubmed">35439407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed Abed A., Khudair Kalaf A. Serological Detection for Toxoplasmosis among Patients with COVID-19 in Thi-Qar Province. Arch. Razi Inst. 2023;78:675–680. doi: 10.22092/ari.2022.359481.2432.</Citation><ArticleIdList><ArticleId IdType="doi">10.22092/ari.2022.359481.2432</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkholy A., Omar G., Elbadawy A., Omar R., Mohamady A., Omar R., Ramadan A., Araby E., Ameen S., Ezzat A., et al. Does Latent Toxoplasmosis Impacts SARS-CoV-2 Infection Severity and Outcome: A Cross-Sectional Study in Benha, Egypt. Benha Med. J. 2023;40:80–96. doi: 10.21608/bmfj.2022.174306.1705.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/bmfj.2022.174306.1705</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbazi A.E., Barati N., Soleymani E., Khandan Del P., Khandan Del A., Azizi N., Bakhtiari M., Motavallihaghi S. Association between toxoplasmosis and COVID-19 infection: A cross-sectional study. Med. Lab. J. 2023;17:10–12.</Citation></Reference><Reference><Citation>Bazmjoo A., Bagherzadeh M.A., Raoofi R., Taghipour A., Mazaherifar S., Sotoodeh H., Ostadi Z., Shadmand E., Jahromi M.A.M., Abdoli A. Toxoplasma gondii, HBV, and HCV co-infection and their correlation with CD4 cells among Iranian HIV-positive patients. Immun. Inflamm. Dis. 2023;11:e794. doi: 10.1002/iid3.794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.794</ArticleId><ArticleId IdType="pmc">PMC9947625</ArticleId><ArticleId IdType="pubmed">36840494</ArticleId></ArticleIdList></Reference><Reference><Citation>Galván-Ramírez M.d.l.L., Salas-Lais A.G., Muñoz-Medina J.E., Fernandes-Matano L., Pérez L.R.R., de León K.F. Association of Toxoplasmosis and COVID-19 in a MexicanPopulation. Microorganisms. 2023;11:1441. doi: 10.3390/microorganisms11061441.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11061441</ArticleId><ArticleId IdType="pmc">PMC10305166</ArticleId><ArticleId IdType="pubmed">37374943</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetkova N., Harizanov R., Ivanova A., Rainova I., Yancheva N., Strashimirov D., Borisova R., Videnova M., Kaneva E., Kaftandjiev I., et al. Study on the Presence of Protozoal Coinfections among Patients with Pneumocystis jirovecii Pneumonia in Bulgaria. Commun. Dis.—Sci. Top. 2023;17:178–183.</Citation></Reference><Reference><Citation>Gouda M.A., AboShabaan H.S., Abdelgawad A.S., Wahed A.S.A., El-Razik K.A.A., Elsaadawy Y., Abdel-Wahab A.A., Hawash Y. Association between breakthrough infection with COVID-19 and Toxoplasma gondii: A cross-sectional study. Sci. Rep. 2023;13:17636. doi: 10.1038/s41598-023-44616-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-44616-3</ArticleId><ArticleId IdType="pmc">PMC10582182</ArticleId><ArticleId IdType="pubmed">37848511</ArticleId></ArticleIdList></Reference><Reference><Citation>Telles J.P.M., Vidal J.E. Cerebral toxoplasmosis with neurological co-infection in people living with AIDS/HIV: Results of a prospective cohort in São Paulo, Brazil. Arq. Neuropsiquiatr. 2023;81:33–39. doi: 10.1055/s-0042-1759758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1759758</ArticleId><ArticleId IdType="pmc">PMC10014194</ArticleId><ArticleId IdType="pubmed">36918005</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdeltawab M.S.A., Fateen M., Saad El-Din S., Elmessiery R.M., Mohammady M.O., Marzouk Sadek K., Medhat E., Hamed A.M.R. Effect of SARS-CoV-2 and Toxoplasma gondii co-infection on IFN-γ and TNF-α expression and its impact on disease severity. Cytokine. 2024;177:156545. doi: 10.1016/j.cyto.2024.156545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2024.156545</ArticleId><ArticleId IdType="pubmed">38368695</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira E.L.G.M., Ferreira I.B., Victorino R.B., Lescano S.A.Z., Giuffrida R., Kmetiuk L.B., Biondo A.W., Santarém V.A. Serosurvey of Toxoplasma gondii and Toxocara spp. co-infection in pregnant women in low-income areas of Brazil. Front. Public Health. 2024;12:1340434. doi: 10.3389/fpubh.2024.1340434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2024.1340434</ArticleId><ArticleId IdType="pmc">PMC10850292</ArticleId><ArticleId IdType="pubmed">38333736</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamed A.T., Nazar S.H., Mohammed A.M.J. Determination of IL33, IL32 and TNF concentrations in Hepatitis C Patients and Possible of Co-infection with Toxoplasma. J. Sci. Med. Life. 2024;2:1–13.</Citation></Reference><Reference><Citation>Hasanzadeh M., Ahmadpour E., Mahami-Oskouei M., Musavi S., Parsaei M., Sarafraz N., Spotin A. Genetic diversity and seroprevalence of Toxoplasma gondii in COVID-19 patients; a first case-control study in Iran. BMC Infect. Dis. 2024;24:42. doi: 10.1186/s12879-023-08964-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08964-9</ArticleId><ArticleId IdType="pmc">PMC10763165</ArticleId><ArticleId IdType="pubmed">38172676</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari-Shakib R., Sadeghi A., Majidi-Shad B., Atrkar-Roshan Z., Sharifdini M. Seroepidemiological study on coinfection of toxoplasmosis and active tuberculosis in Northern Iran: A case control study. J. Parasit. Dis. 2024;48:247–252. doi: 10.1007/s12639-024-01657-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12639-024-01657-3</ArticleId><ArticleId IdType="pmc">PMC11147986</ArticleId><ArticleId IdType="pubmed">38840872</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouda M.A., Saied S.A., Edrees A., Mostafa R.G., Elfert A., Seleem A.A., Shams A., Afify S. Effect of concurrent infection of Helicobacter pylori with Toxoplasma gondii infection on gastric pathology. BMC Infect. Dis. 2024;24:408. doi: 10.1186/s12879-024-09270-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09270-8</ArticleId><ArticleId IdType="pmc">PMC11020820</ArticleId><ArticleId IdType="pubmed">38627630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdy D.A., Eid R.A., Abdel-Tawab H., El-Badry M.A., Abdallah A.M., El Wahab W.M.A. Impact of latent toxoplasmosis on pneumonic and non-pneumonic COVID-19 patients with estimation of relevant oxidative stress biomarkers. Folia Parasitol. 2024;71:2024.008. doi: 10.14411/fp.2024.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.14411/fp.2024.008</ArticleId><ArticleId IdType="pubmed">38628099</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharani K., Dian S., Ganiem A.R., Imran D., Estiasari R., Ardiansyah E., Andini P.W., Kristina F., Pangeran D., Chaidir L., et al. Clinical presentation, management, and outcome of suspected central nervous system infections in Indonesia: A prospective cohort study. Infection. 2024;52:583–595. doi: 10.1007/s15010-023-02170-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-023-02170-0</ArticleId><ArticleId IdType="pmc">PMC10954958</ArticleId><ArticleId IdType="pubmed">38315377</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>